Hybrid argon plasma coagulation for chronic radiation-induced proctitis following pelvic chemoradiotherapy for cervical adenocarcinoma: a case report

Hybrid argon plasma coagulation for chronic radiation-induced proctitis following pelvic chemoradiotherapy for cervical adenocarcinoma: a case report Chronic radiation-induced proctitis is a common complication of pelvic radiotherapy that frequently presents with rectal bleeding and mucosal friability.Argon plasma coagulation (APC) is considered the first-line treatment for this condition [1]; however, it is associated with complications, such as rectal pain, ulceration, and perforation [2, 3].Hybrid APC (hAPC), which combines high-pressure submucosal fluid injection with thermal ablation [4], has shown promise in achieving hemostasis while minimizing the depth of thermal injury to the muscular layer ( Fig. 1).